# The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases

> **NCT00145665** · PHASE1,PHASE2 · TERMINATED · sponsor: **Radboud University Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Colorectal Neoplasms
- Liver Neoplasms

## Interventions

- **PROCEDURE:** FLT-PET scan

## Key facts

- **NCT ID:** NCT00145665
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01
- **Primary completion:** 2011-12
- **Final completion:** 2012-12
- **Target enrollment:** 80 (ESTIMATED)
- **Why stopped:** no accrual achieved
- **Last updated:** 2011-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145665, "The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00145665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*